Nippon Chemiphar Co., Ltd. (4539.T)
JPY 1436.0
(0.0%)
JPY 1436.0
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 7.73 Billion JPY | -5.46% |
| 2022 | 8.18 Billion JPY | -9.8% |
| 2021 | 9.07 Billion JPY | -20.71% |
| 2020 | 11.44 Billion JPY | -8.85% |
| 2019 | 12.55 Billion JPY | -13.57% |
| 2018 | 14.52 Billion JPY | -8.03% |
| 2017 | 15.79 Billion JPY | -2.73% |
| 2016 | 16.24 Billion JPY | -3.32% |
| 2015 | 16.79 Billion JPY | 0.2% |
| 2014 | 16.76 Billion JPY | -0.01% |
| 2013 | 16.76 Billion JPY | -1.52% |
| 2012 | 17.02 Billion JPY | 8.84% |
| 2011 | 15.64 Billion JPY | 8.84% |
| 2010 | 14.37 Billion JPY | 14.66% |
| 2009 | 12.53 Billion JPY | 5.14% |
| 2008 | 11.92 Billion JPY | -1.8% |
| 2007 | 12.13 Billion JPY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 2.02 Billion JPY | -3.44% |
| 2024 Q1 | 2.09 Billion JPY | 10.62% |
| 2023 FY | 7.73 Billion JPY | -5.46% |
| 2023 Q3 | 2.21 Billion JPY | 24.13% |
| 2023 Q2 | 1.78 Billion JPY | -3.73% |
| 2023 Q1 | 1.85 Billion JPY | 0.87% |
| 2023 Q4 | 1.89 Billion JPY | -14.42% |
| 2022 FY | 8.18 Billion JPY | -9.8% |
| 2022 Q1 | 2.22 Billion JPY | 11.87% |
| 2022 Q4 | 1.83 Billion JPY | -12.16% |
| 2022 Q2 | 2.03 Billion JPY | -8.49% |
| 2022 Q3 | 2.08 Billion JPY | 2.6% |
| 2021 Q4 | 1.98 Billion JPY | -28.32% |
| 2021 Q1 | 2.04 Billion JPY | -23.86% |
| 2021 Q2 | 2.26 Billion JPY | 10.65% |
| 2021 Q3 | 2.77 Billion JPY | 22.57% |
| 2021 FY | 9.07 Billion JPY | -20.71% |
| 2020 Q3 | 3.37 Billion JPY | 19.19% |
| 2020 Q4 | 2.68 Billion JPY | -20.31% |
| 2020 FY | 11.44 Billion JPY | -8.85% |
| 2020 Q1 | 2.55 Billion JPY | -5.54% |
| 2020 Q2 | 2.82 Billion JPY | 10.68% |
| 2019 Q1 | 3.7 Billion JPY | 6.99% |
| 2019 FY | 12.55 Billion JPY | -13.57% |
| 2019 Q2 | 3.17 Billion JPY | -14.44% |
| 2019 Q3 | 2.97 Billion JPY | -6.28% |
| 2019 Q4 | 2.7 Billion JPY | -8.95% |
| 2018 Q2 | 3.49 Billion JPY | -3.93% |
| 2018 Q1 | 3.64 Billion JPY | 5.44% |
| 2018 Q4 | 3.46 Billion JPY | -11.72% |
| 2018 FY | 14.52 Billion JPY | -8.03% |
| 2018 Q3 | 3.92 Billion JPY | 12.18% |
| 2017 Q2 | 3.95 Billion JPY | -1.15% |
| 2017 Q1 | 3.99 Billion JPY | 1.24% |
| 2017 FY | 15.79 Billion JPY | -2.73% |
| 2017 Q4 | 3.45 Billion JPY | -21.4% |
| 2017 Q3 | 4.39 Billion JPY | 11.16% |
| 2016 Q2 | 3.91 Billion JPY | -2.32% |
| 2016 Q4 | 3.94 Billion JPY | -9.47% |
| 2016 FY | 16.24 Billion JPY | -3.32% |
| 2016 Q3 | 4.36 Billion JPY | 11.33% |
| 2016 Q1 | 4.01 Billion JPY | -1.52% |
| 2015 Q4 | 4.07 Billion JPY | -11.5% |
| 2015 FY | 16.79 Billion JPY | 0.2% |
| 2015 Q3 | 4.6 Billion JPY | 11.43% |
| 2015 Q2 | 4.13 Billion JPY | 3.43% |
| 2015 Q1 | 3.99 Billion JPY | 7.77% |
| 2014 Q3 | 4.7 Billion JPY | 17.44% |
| 2014 Q4 | 3.7 Billion JPY | -21.27% |
| 2014 FY | 16.76 Billion JPY | -0.01% |
| 2014 Q1 | 4.34 Billion JPY | 15.03% |
| 2014 Q2 | 4 Billion JPY | -7.8% |
| 2013 Q3 | 4.78 Billion JPY | 18.36% |
| 2013 Q4 | 3.77 Billion JPY | -21.03% |
| 2013 FY | 16.76 Billion JPY | -1.52% |
| 2013 Q1 | 4.16 Billion JPY | 12.28% |
| 2013 Q2 | 4.04 Billion JPY | -2.86% |
| 2012 Q3 | 4.55 Billion JPY | 4.52% |
| 2012 Q1 | 4.41 Billion JPY | 27.6% |
| 2012 Q4 | 3.7 Billion JPY | -18.59% |
| 2012 FY | 17.02 Billion JPY | 8.84% |
| 2012 Q2 | 4.35 Billion JPY | -1.25% |
| 2011 Q2 | 3.77 Billion JPY | -1.56% |
| 2011 Q3 | 4.56 Billion JPY | 20.94% |
| 2011 Q4 | 3.45 Billion JPY | -24.36% |
| 2011 FY | 15.64 Billion JPY | 8.84% |
| 2011 Q1 | 3.83 Billion JPY | 8.66% |
| 2010 FY | 14.37 Billion JPY | 14.66% |
| 2010 Q3 | 3.91 Billion JPY | 11.35% |
| 2010 Q1 | 3.41 Billion JPY | 5.77% |
| 2010 Q4 | 3.53 Billion JPY | -9.74% |
| 2010 Q2 | 3.51 Billion JPY | 2.99% |
| 2009 Q2 | 2.99 Billion JPY | -0.37% |
| 2009 Q1 | 3 Billion JPY | 4.41% |
| 2009 FY | 12.53 Billion JPY | 5.14% |
| 2009 Q4 | 3.22 Billion JPY | -2.33% |
| 2009 Q3 | 3.3 Billion JPY | 10.25% |
| 2008 Q2 | 3.03 Billion JPY | 0.0% |
| 2008 Q4 | 2.88 Billion JPY | -7.93% |
| 2008 FY | 11.92 Billion JPY | -1.8% |
| 2008 Q3 | 3.12 Billion JPY | 3.17% |
| 2007 FY | 12.13 Billion JPY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 48.75 Billion JPY | 84.128% |
| Takeda Pharmaceutical Company Limited | 2184.96 Billion JPY | 99.646% |
| Sumitomo Pharma Co., Ltd. | 187.98 Billion JPY | 95.884% |
| Shionogi & Co., Ltd. | 369.08 Billion JPY | 97.903% |
| Wakamoto Pharmaceutical Co.,Ltd. | 3.54 Billion JPY | -118.535% |
| Nippon Shinyaku Co., Ltd. | 97.01 Billion JPY | 92.024% |
| Kaken Pharmaceutical Co., Ltd. | 38.22 Billion JPY | 79.755% |
| Eisai Co., Ltd. | 586.41 Billion JPY | 98.68% |
| Morishita Jintan Co., Ltd. | 5.99 Billion JPY | -29.01% |
| Hisamitsu Pharmaceutical Co., Inc. | 78.97 Billion JPY | 90.201% |
| Mochida Pharmaceutical Co., Ltd. | 52.07 Billion JPY | 85.139% |
| Fuso Pharmaceutical Industries,Ltd. | 13.51 Billion JPY | 42.754% |
| Tsumura & Co. | 68.81 Billion JPY | 88.756% |
| Kissei Pharmaceutical Co., Ltd. | 37.34 Billion JPY | 79.277% |
| Torii Pharmaceutical Co., Ltd. | 24.79 Billion JPY | 68.788% |
| Towa Pharmaceutical Co., Ltd. | 81.38 Billion JPY | 90.492% |
| Fuji Pharma Co., Ltd. | 16.51 Billion JPY | 53.146% |
| Zeria Pharmaceutical Co., Ltd. | 50.18 Billion JPY | 84.58% |
| KYORIN Holdings, Inc. | 51.4 Billion JPY | 84.946% |
| Taiko Pharmaceutical Co.,Ltd. | 1.07 Billion JPY | -617.146% |
| Daito Pharmaceutical Co.,Ltd. | 9.83 Billion JPY | 21.354% |
| SymBio Pharmaceuticals Limited | 4.41 Billion JPY | -75.425% |
| MedRx Co., Ltd | 26 Million JPY | -29661.538% |
| Mizuho Medy Co.,Ltd. | 8.02 Billion JPY | 3.585% |
| Solasia Pharma K.K. | 337 Million JPY | -2196.142% |
| Modalis Therapeutics Corporation | -731 Thousand JPY | 1058649.932% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 30.66 Billion JPY | 74.766% |
| Sawai Group Holdings Co., Ltd. | 54.31 Billion JPY | 85.755% |
| Cyfuse Biomedical K.K. | 37.74 Million JPY | -20401.272% |
| Toho Holdings Co., Ltd. | 112.98 Billion JPY | 93.151% |
| Koa Shoji Holdings Co.,Ltd. | 6.63 Billion JPY | -16.543% |